Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide in Adults With Type 2 Diabetes and Chronic Kidney Disease in China
NCT07900438Phase 4Recruiting
- Sponsor
- Novo Nordisk
- Start
- Oct 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), sponsored by Novo Nordisk. Started Oct 2026; status: recruiting.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07900438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07900438.